Extending survival of stage IV non-small cell lung cancer.
about
Palliative Thoracic Radiotherapy for Lung Cancer: What Is the Impact of Total Radiation Dose on Survival?A retrospective study of docetaxel and bevacizumab as a second- or later-line chemotherapy for non-small cell lung cancer.Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III studyIdentifying erlotinib-sensitive non-small cell lung carcinoma tumors in mice using [(11)C]erlotinib PET.BMS-754807 is cytotoxic to non-small cell lung cancer cells and enhances the effects of platinum chemotherapeutics in the human lung cancer cell line A549.A retrospective analysis of safety and efficacy of weekly nab-paclitaxel as second-line chemotherapy in elderly patients with advanced squamous non-small-cell lung carcinoma.Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivityUnique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis.Epiregulin as a therapeutic target in non-small-cell lung cancerNanomedicine as an emerging platform for metastatic lung cancer therapy.Accuracy of Tokuhashi score system in predicting survival of lung cancer patients with vertebral metastasis.A Four-Tiered Prognostic Score for Patients Receiving Palliative Thoracic Radiotherapy for Lung Cancer.Impact of early palliative interventions on the outcomes of care for patients with non-small cell lung cancer.Reliability of using circulating tumor cells for detecting epidermal growth factor receptor mutation status in advanced non-small-cell lung cancer patients: a meta-analysis and systematic review.Combining immunotherapy with radiation therapy in thoracic oncology
P2860
Q33625201-0692BE4D-55CF-4591-AFCE-C987CBC1E0EFQ33857726-898F4FF7-24EC-403F-AAB0-4C6B05232FA5Q34996046-823FD2F7-B687-487E-A8F3-1CBDC33FF84EQ35264584-58E4D6C0-D9A2-4DE2-8361-0A6E10DD44ABQ35940305-9B23B32E-59BC-4A0C-8EB9-E271E2B64DB3Q36617748-02A0349F-B5F8-4A09-A769-ECBCF30E8DFEQ36634788-639D50BB-96DD-4FF0-B869-CDC415A3C351Q36772120-352B9606-1311-4552-98D0-C15AC7AC222CQ37566850-A5084AF7-E82C-4F6E-85C3-A8C5DE56AEBEQ38463092-3F650490-BBBC-4871-B077-88C088FF2009Q40533197-E1B2370F-F9A1-4C7B-8D7E-57FF5D0BD27DQ47214374-7081ECBB-1A0B-4B53-9F14-6CAC68A6294EQ53096925-91D6B922-55B0-4605-8BA5-DB3D74D40C87Q54120286-B2FFC177-C003-4FC2-98B2-1E9CE972753EQ58804834-D37B7A9D-4FF3-446C-9341-ADCE8DF4033A
P2860
Extending survival of stage IV non-small cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Extending survival of stage IV non-small cell lung cancer.
@en
type
label
Extending survival of stage IV non-small cell lung cancer.
@en
prefLabel
Extending survival of stage IV non-small cell lung cancer.
@en
P2093
P1433
P1476
Extending survival of stage IV non-small cell lung cancer
@en
P2093
Giorgio Vittorio Scagliotti
Matteo Giaj Levra
Silvia Novello
Simona Carnio
P356
10.1053/J.SEMINONCOL.2013.12.013
P50
P577
2013-12-21T00:00:00Z